CMTA1 polyclonal antibody, anti-human, mouse

Background:
disease:Defects in CAMTA1 are detected in patients with oligodendroglioma and astrocytoma.,Transcriptional activator. May act as a tumor suppressor.,induction:Detected at low levels at interphase and in resting cells. Up-regulated during S-phase and mitosis. Levels decrease at the end of mitosis.,Belongs to the CAMTA family.,Contains 1 CG-1 DNA-binding domain.,Contains 1 IPT/TIG domain.,Contains 3 ANK repeats.,Contains 3 IQ domains.,subunit:May interact with calmodulin .,tissue specificity:Detected in whole brain, cerebellum, brain cortex, occipital lobe, frontal lobe, temporal lobe, putamen, heart and kidney. Detected in neuroblastic-type cultured neuroblastoma cells.,

Research Area: Cancer, Epigenetics and nuclear

Synonyms: Calmodulin-binding transcription activator 1

Immunogen: The antiserum was produced against synthesized peptide derived from human AMPK alpha around the phosphorylation site of Thr172. AA range:140-189

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Formulation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Concentration: 1 mg/ml

Storage:
-20°C for 1 year